The invention discloses a composition comprising a three party fusion protein, oh 40. It is also disclosed that methods of enhancing immune response, with mammalian commitment, are on the surface of antigen receptor O-40 T cells. It includes the synthesis of three party fusion proteins in mammals and the acceptable carrier of drugs - Oh 40.
展开▼